NOTES
TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER
30, 2021
(UNAUDITED)
NOTE
1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Globis
Acquisition Corp. (the “Company”) was incorporated in Delaware on August 21, 2020. The Company is a blank check company formed
for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses or entities (the “Business Combination”).
The
Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early
stage and emerging growth companies.
As
of September 30, 2021, the Company had not commenced any operations. All activity for the period from August 21, 2020 (inception) through
September 30, 2021 relates to the Company’s formation, initial public offering (“Initial Public Offering”), which is
described below, and search for a Business Combination. The Company will not generate any operating revenues until after the completion
of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds
derived from the Initial Public Offering.
The
registration statement for the Company’s Initial Public Offering was declared effective on December 10, 2020. On December 15, 2020,
the Company consummated the Initial Public Offering of 11,500,000 units (the “Units” and, with respect to the shares of common
stock included in the Units sold, the “Public Shares,” which included the full exercise by the underwriter of its over-allotment
option in the amount of 1,500,000 Units, at $10.00 per Unit), generating gross proceeds of $115,000,000, which is described in Note 4.
Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 4,188,889 warrants (the “Private Warrants”)
at a price of $0.75 per Private Warrant and 100,833 units (the “Placement Units” and, together with the Private Warrants,
the “Private Securities”) at a price of $10.00 per Placement Unit in a private placement to Globis SPAC LLC and Up and Up
Capital, LLC, an affiliate of Chardan Capital Markets, LLC, the representative of the underwriters (“Up and Up” and, collectively
with Globis SPAC LLC, the “Sponsors”), which is described in Note 5.
Transaction
costs amounted to $6,541,841 consisting of $2,300,000 of underwriting fees, $4,025,000 representing 402,500 shares of common stock issued,
which the underwriters are entitled to receive upon the consummation of a Business Combination (the “equity participation shares”),
and $216,841 of other offering costs.
Following
the closing of the Initial Public Offering on December 15, 2020, an amount of $116,150,000 ($10.10 per Unit) from the net proceeds of
the sale of the Units in the Initial Public Offering and the sale of the Private Securities was placed in a trust account (the “Trust
Account”), located in the United States and held as cash or invested only in U.S. government securities, within the meaning set
forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company
that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act,
as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds
in the Trust Account, as described below.
The
Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of the Private Securities, although substantially all of the net proceeds are intended to be applied generally toward completing
a Business Combination. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the
assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement to enter
into an initial Business Combination. The Company intends to only complete a Business Combination if the post-Business Combination company
owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target
sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment
Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully.
The
Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a
Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means
of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender
offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for
a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.10 per Public Share, plus any pro rata interest
earned on the funds held in the Trust Account and not previously released to the Company to pay its tax or dissolution obligations).
There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.
GLOBIS
ACQUISITION CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER
30, 2021
(UNAUDITED)
The
Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or
upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted
in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder
vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended
and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities
and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially the same information
as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction
is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem
shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company
seeks stockholder approval in connection with a Business Combination, the Sponsors have agreed to vote their Founder Shares (as defined
in Note 6), Placement Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor
of approving a Business Combination. The underwriters have also agreed to vote their equity participation shares and any public shares
they own in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares,
without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination.
Notwithstanding
the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender
offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of
such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section
13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares
with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.
The
Sponsors and the Company’s officers and directors will agree (a) to waive redemption rights with respect to the Founder Shares,
Placement Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an
amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation
to allow redemption in connection with the Company’s initial Business Combination and certain amendments to the Amended and Restated
Certificate of Incorporation or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with
respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless the Company
provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
The
Company will have until December 15, 2021 to complete a Business Combination; provided, however, if the Company anticipates that it may
not be able to consummate a Business Combination by December 15, 2021, the Company may, by resolution of the board of directors if requested
by Globis SPAC LLC, extend the period of time to consummate a Business Combination up to two times, each by an additional three months
(up until June 15, 2022 to complete a Business Combination), subject to the deposit of additional funds into the Trust Account by one
or both of the Sponsors or their affiliates or designees (the “Combination Period”). The Company’s stockholders will
not be entitled to vote or redeem their shares in connection with any such extension. Pursuant to the terms of the Company’s Amended
and Restated Certificate of Incorporation, in order for the time available for the Company to consummate a Business Combination to be
extended, one or both of the Sponsors or their affiliates or designees, upon five days’ advance notice prior to the applicable
deadline, must deposit into the trust account $1,150,000 ($0.10 per Unit, up to an aggregate of $2,300,000), on or prior to the date
of the applicable deadline, for each three month extension. Any such payments would be made in the form of a non-interest bearing loan
and would be repaid, if at all, from funds released to the Company upon completion of a Business Combination.
If
the Company is unable to complete a Business Combination within the Combination Period and stockholders do not approve an amendment to
the Amended and Restated Certificate of Incorporation to extend this date, the Company will (i) cease all operations except for the purpose
of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest (which interest
shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding
Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to
receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following
such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve
and liquidate, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Delaware law to provide for claims
of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect
to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination
Period.
The
holders of the Founder Shares and Placement Shares have agreed to waive liquidation rights with respect to such shares if the Company
fails to complete a Business Combination within the Combination Period. However, if the Sponsors acquire Public Shares in or after the
Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails
to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their liquidation rights with
respect to the equity participation shares (see Note 7) in the event the Company does not complete a Business Combination within the
Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available
to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets
remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.10).
GLOBIS
ACQUISITION CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER
30, 2021
(UNAUDITED)
In
order to protect the amounts held in the Trust Account, the Sponsors will agree to be liable to the Company if and to the extent any
claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has
discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.10 per Public Share
or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions
in the value of trust assets, in each case net of the interest which may be withdrawn to pay the Company’s tax obligation and up
to $100,000 for liquidation expenses, except as to any claims by a third party who executed a waiver of any and all rights to seek access
to the Trust Account (even if such waiver is deemed to be unenforceable) and except as to any claims under the Company’s indemnity
of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as
amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third
party, the Sponsors will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce
the possibility that the Sponsors will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors,
service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the
Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity
The
Company has principally financed its operations from inception using proceeds from the sale of its equity securities to its stockholders
prior to the Initial Public Offering and such amount of proceeds from the Initial Public Offering that were placed in an account outside
of the Trust Account for working capital purposes. As of September 30, 2021, the Company had cash of $8,413 held outside of the Trust
Account, $116,155,627 held in the Trust Account to be used for a Business Combination, and adjusted working capital deficit of $1,037,663,
which excludes $150,000 of franchise taxes payable.
The
Company may raise additional capital through loans or additional investments from the Sponsors, officers, directors, or their affiliates.
Other than as described above and in Note 6, the Company’s officers, directors and the Sponsors and their affiliates may, but are
not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet
the Company’s working capital needs.
The
Company does not believe it will need to raise additional funds in order to meet expenditures required for operating its business following
its issuance of an unsecured convertible promissory note on January 11, 2021 (the “Note”) to Globis SPAC LLC, or its assigns
or successors in interest (the “Lender”), providing for borrowings from time to time of up to an aggregate of $1,000,000.
On July 19, 2021 the Note was amended to increase the principal amount of the Note to $2,000,000 and on October 13, 2021, the Note was
further amended to increase the principal amount of the Note to $3,000,000. None of the Sponsors, nor any of the stockholders, officers
or directors, or third parties are under any obligation to advance funds to, or invest in, the Company, except as discussed above. Accordingly,
the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required
to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of
a potential Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially
acceptable terms, if at all. Even if the Company can obtain sufficient financing or raise additional capital, it only has until December
15, 2021 to consummate a Business Combination (or June 15, 2022 if the Company extends the period of time to consummate a Business Combination
up to two times, each by an additional three months). There is no assurance that the Company will be able to do so prior to December
15, 2021 (or June 15, 2022 if the Company extends the period of time to consummate a Business Combination up to two times, each by an
additional three months).
Risks
and Uncertainties
Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily
determinable as of the date of the financial statement. The financial statement does not include any adjustments that might result from
the outcome of this uncertainty.
NOTE
2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
In
connection with the preparation of the Company’s financial statements as of September 30, 2021, management determined it should
restate the Company’s previously reported financial statements. During the quarter ended September 30, 2021, the Company determined that at the
closing of the Company’s Initial Public Offering (including the sale of the shares issued pursuant to the exercise of the underwriters’
overallotment) it had improperly valued its common stock subject to possible redemption at the closing of the Company’s Initial
Public Offering and at the closing of the sale of shares pursuant to the exercise of the underwriters’ overallotment, it had improperly
classified certain of its common stock subject to possible redemption. The Company previously determined the common stock subject to
possible redemption to be equal to the redemption value of $10.10 per share of common stock while also taking into consideration that
in accordance with the Company’s Charter, a redemption cannot result in net tangible assets being less than $5,000,001. Management
determined that the common stock issued in the Initial Public Offering and pursuant to the exercise of the underwriters’ overallotment
can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control. Therefore,
management concluded that temporary equity should include all common stock subject to possible redemption, resulting in the common stock
subject to possible redemption being equal to its redemption value. As a result, management has noted a classification adjustment related
to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the common stock subject to
possible redemption with the offset recorded to additional paid-in capital and common stock
In
connection with the change in presentation for the common stock subject to redemption, the Company also restated its income (loss)
per share of common stock calculation to allocate net income (loss) evenly to the total shares of common stock. This
presentation contemplates a Business Combination as the most likely outcome, in which case, all shares of common stock share pro rata
in the income (loss) of the Company.
The
impact of the restatement on the Company’s historical financial statements is reflected in the following tables:
SCHEDULE OF ERROR CORRECTIONS AND PRIOR PERIOD ADJUSTMENTS
|
|
As Previously
Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
Condensed Balance Sheet as of March 31, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock subject to possible redemption
|
|
$
|
111,205,807
|
|
|
$
|
4,944,193
|
|
|
$
|
116,150,000
|
|
Common stock
|
|
$
|
404
|
|
|
$
|
(49
|
)
|
|
$
|
355
|
|
Additional paid-in capital
|
|
$
|
5,453,448
|
|
|
$
|
(4,944,144
|
)
|
|
$
|
509,304
|
|
Accumulated deficit
|
|
$
|
(453,845
|
)
|
|
$
|
—
|
|
|
$
|
(453,845
|
)
|
Total Stockholders’ Equity (Deficit)
|
|
$
|
5,000,007
|
|
|
$
|
(4,944,193
|
)
|
|
$
|
55,814
|
|
Number of shares of common stock subject to possible redemption
|
|
|
11,010,476
|
|
|
|
(489,524
|
)
|
|
|
11,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Balance Sheet as of June 30, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock subject to possible redemption
|
|
$
|
110,858,319
|
|
|
$
|
5,291,681
|
|
|
$
|
116,150,000
|
|
Common stock
|
|
$
|
407
|
|
|
$
|
(52
|
)
|
|
$
|
355
|
|
Additional paid-in capital
|
|
$
|
5,800,933
|
|
|
$
|
(5,291,629
|
)
|
|
$
|
509,304
|
|
Accumulated deficit
|
|
$
|
(801,336
|
)
|
|
$
|
—
|
|
|
$
|
(801,336
|
)
|
Total Stockholders’ Equity (Deficit)
|
|
$
|
5,000,004
|
|
|
$
|
(5,291,681
|
)
|
|
$
|
(291,677
|
)
|
Number of shares of common stock subject to possible redemption
|
|
|
10,976,071
|
|
|
|
523,929
|
|
|
|
11,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Statement of Operations for the Three Months Ended March 31, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption
|
|
|
11,046,512
|
|
|
|
453,488
|
|
|
|
11,500,000
|
|
Basic and diluted net income (loss) per share, common stock subject to possible redemption
|
|
$
|
—
|
|
|
$
|
(0.02
|
)
|
|
$
|
(0.02
|
)
|
Basic and diluted weighted average shares outstanding, Non-redeemable common stock
|
|
|
4,004,321
|
|
|
|
(453,488
|
)
|
|
|
3,550,833
|
|
Basic and diluted net income (loss) per share, Non-redeemable common stock
|
|
$
|
(0.09
|
)
|
|
$
|
0.07
|
|
|
$
|
(0.02
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the Three Months Ended June 30, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption
|
|
|
11,010,476
|
|
|
|
489,524
|
|
|
|
11,500,000
|
|
Basic and diluted net income (loss) per share, common stock subject to possible redemption
|
|
$
|
—
|
|
|
$
|
(0.02
|
)
|
|
$
|
(0.02
|
)
|
Basic and diluted weighted average shares outstanding, Non-redeemable common stock
|
|
|
4,040,357
|
|
|
|
(489,524
|
)
|
|
|
3,550,833
|
|
Basic and diluted net income (loss) per share, Non-redeemable common stock
|
|
$
|
(0.09
|
)
|
|
$
|
0.07
|
|
|
$
|
(0.02
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations for the Six Months Ended June 30, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption
|
|
|
11,028,394
|
|
|
|
471,606
|
|
|
|
11,500,000
|
|
Basic and diluted net income (loss) per share, common stock subject to possible redemption
|
|
$
|
—
|
|
|
$
|
(0.05
|
)
|
|
$
|
(0.05
|
)
|
Basic and diluted weighted average shares outstanding, Non-redeemable common stock
|
|
|
4,022,439
|
|
|
|
(471,606
|
)
|
|
|
3,550,833
|
|
Basic and diluted net income (loss) per share, Non-redeemable common stock
|
|
$
|
(0.18
|
)
|
|
$
|
0.13
|
|
|
$
|
(0.05
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Statement of Changes in Stockholders’ Equity
(Deficit) for the Three Months Ended March 31, 2021 (unaudited)
|
|
|
As
Previously
Reported
|
|
|
|
Adjustment
|
|
|
|
As
Restated
|
|
Change in value of common stock subject to possible redemption
|
|
$
|
363,065
|
|
|
$
|
(363,065
|
)
|
|
$
|
—
|
|
Total Stockholders’ Equity
|
|
$
|
5,000,007
|
|
|
|
(4,944,193
|
)
|
|
$
|
55,814
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the
Three Months Ended June 30, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in value of common stock subject to possible redemption
|
|
$
|
347,488
|
|
|
$
|
(347,488
|
)
|
|
$
|
—
|
|
Total Stockholders’ Equity (Deficit)
|
|
$
|
5,000,004
|
|
|
$
|
(5,291,681
|
)
|
|
$
|
(291,677
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Statement of Cash Flows for the three months ended March 31, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Cash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in value of common stock subject to possible redemption
|
|
$
|
(363,965
|
)
|
|
$
|
363,965
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Statement of Cash Flows for the six months ended June 30, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Cash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in value of common stock subject to possible redemption
|
|
$
|
(711,453
|
)
|
|
$
|
711,453
|
|
|
$
|
—
|
|
NOTE
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.
The
accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K
as filed with the SEC on March 31, 2021, as amended by the Amendment No. 1 to the Annual Report on Form 10-K/A as filed with the SEC
on December 7, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily
indicative of the results to be expected for the year ending December 31, 2021 or for any future periods.
GLOBIS
ACQUISITION CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER
30, 2021
(UNAUDITED)
Emerging
Growth Company
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of
2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.
Use
of Estimates
The
preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting period.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events
Cash
and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of September 30, 2021 or December 31, 2020.
Marketable
Securities Held in Trust Account
At
September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in money market funds which
invest U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities.
Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from
the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in the Trust
Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are
determined using available market information.
Common
Stock Subject to Possible Redemption
The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified
as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features
redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not
solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’
equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s
control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at
redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.
The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock
to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the
Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable common
stock resulted in charges against additional paid-in capital and accumulated deficit.
At
September 30, 2021 and December 31, 2020, the common stock reflected in the condensed balance sheets are reconciled in the following
table:
SCHEDULE OF CONDENSED BALANCE SHEET
Gross
proceeds
|
|
$
|
115,000,000
|
|
Less:
|
|
|
|
|
Common
Stock issuance costs
|
|
$
|
(2,516,841
|
)
|
Plus:
|
|
|
|
|
Accretion
of carrying value to redemption value
|
|
$
|
3,666,841
|
|
Common
Stock subject to possible redemption
|
|
$
|
116,150,000
|
|
Income
Taxes
The
Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition
of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets
and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally
requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not
be realized.
GLOBIS
ACQUISITION CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER
30, 2021
(UNAUDITED)
ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an company’s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more -likely -than -not to be sustained upon
examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income
tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December
31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material
deviation from its position. The Company has been subject to income tax examinations by major taxing authorities since inception.
On
March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws
are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things
(i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”) for 2019
and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be
immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting
federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate
a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company’s
full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.
Net
Income (Loss) per Common Share
The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss)
per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Common
Stock is excluded from earnings per share as the redemption value approximates fair value.
The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement, as described in Note 5, since the exercise of the warrants is contingent upon the occurrence
of future events. The warrants are exercisable to purchase 15,789,722 Common Stock in the aggregate. As of September 30, 2021 and 2020,
the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common shares
and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic net loss per common
share for the periods presented.
The following table reflects
the calculation of basic and diluted net loss per common share (in dollars, except per share amounts):
SCHEDULE OF CALCULATION OF BASIC AND DILUTED NET LOSS PER COMMON SHARE
|
|
Redeemable
|
|
|
Non-redeemable
|
|
|
Redeemable
|
|
|
Non-redeemable
|
|
|
Non-redeemable
|
|
|
|
|
|
|
|
|
|
For the Period from
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
August 21, 2020
(Inception)
Through
|
|
|
|
September 30, 2021
|
|
|
September 30, 2021
|
|
|
September 30, 2020
|
|
|
|
Redeemable
|
|
|
Non-redeemable
|
|
|
Redeemable
|
|
|
Non-redeemable
|
|
|
Non-redeemable
|
|
|
|
common stock
|
|
|
common stock
|
|
|
common stock
|
|
|
common stock
|
|
|
common stock
|
|
Basic and diluted net loss per common share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net loss, as adjusted
|
|
$
|
(680,303
|
)
|
|
$
|
(210,056
|
)
|
|
$
|
(1,223,906
|
)
|
|
$
|
(377,903
|
)
|
|
$
|
(1,000
|
)
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted weighted average shares outstanding
|
|
|
11,500,000
|
|
|
|
3,550,833
|
|
|
|
11,500,000
|
|
|
|
3,550,833
|
|
|
|
2,500,000
|
|
Basic and diluted net loss per common share
|
|
$
|
(0.06
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.11
|
)
|
|
$
|
(0.11
|
)
|
|
$
|
(0.00
|
)
|
GLOBIS
ACQUISITION CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER
30, 2021
(UNAUDITED)
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account
and management believes the Company is not exposed to significant risks on such account.
Fair
Value of Financial Instruments
The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value
Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheet, primarily due to their
short-term nature.
Fair
Value Measurements
Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
|
●
|
Level
1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
|
|
●
|
Level
2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
and
|
|
●
|
Level
3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
|
In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.
Recent
Accounting Standards
In
August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an
Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major
separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts
to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early
adoption permitted. The Company adopted ASU 2020-06 effective as of January 1, 2021. The adoption of ASU 2020-06 did not have an impact
on the Company’s financial statements.
Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the accompanying condensed financial statements.
NOTE
4. INITIAL PUBLIC OFFERING
Pursuant
to the Initial Public Offering, the Company sold 11,500,000 Units, which included a full exercise by the underwriters of their over-allotment
option in the amount of 1,500,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of common stock and one redeemable
warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50
per share, subject to adjustment (see Note 8).
GLOBIS
ACQUISITION CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER
30, 2021
(UNAUDITED)
NOTE
5. PRIVATE PLACEMENT
Simultaneously
with the closing of the Initial Public Offering, Globis SPAC LLC purchased 3,688,889 Private Warrants at a purchase price of $0.75 per
Private Warrant, for an aggregate purchase price of $2,766,667 and Up and Up purchased 500,000 Private Warrants at a purchase price of
$0.75 per Private Warrant, for an aggregate purchase price of $375,000. Each Private Warrant entitles the holder to purchase one share
of common stock at a price of $11.50 per share, subject to adjustment (see Note 8). In addition, Up and Up purchased an aggregate of
100,833 Placement Units at a purchase price of $10.00 per Placement Unit, or $1,008,333 in the aggregate. Each Placement Unit consists
of one share of common stock (“Placement Share”) and one redeemable warrant (“Placement Warrant”). Each Placement
Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 8).
The
proceeds from the sale of the Private Securities were added to the net proceeds from the Initial Public Offering held in the Trust Account.
If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Securities
held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and
the Private Securities and all underlying securities will expire worthless.
NOTE
6. RELATED PARTY TRANSACTIONS
Founder
Shares
On
September 1, 2020, Globis SPAC LLC purchased 2,875,000 shares of the Company’s common stock for an aggregate price of $25,000.
On December 7, 2020, the Company sold an additional 172,500 shares of the Company’s common stocks to Up and Up for an aggregate
price of $1,500, resulting in a total of shares of common stock being sold to the Sponsors (the “Founder Shares”)
and being issued and outstanding, of which an aggregate of up to 397,500 shares were subject to forfeiture to the extent that the underwriters’
over-allotment option was not exercised in full or in part, so that the Sponsors would own approximately 21% of the Company’s issued
and outstanding shares after the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment
option on December 15, 2020, no Founder Shares are currently subject to forfeiture.
The
Sponsors agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the date of the consummation
of a Business Combination or the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or
other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common
stock for cash, securities or other property.
Administrative
Support Agreement
The
Company entered into an agreement, commencing on December 15, 2020 the effective date of the Initial Public Offering, to pay an affiliate
of Globis SPAC LLC a total of $10,000 per month for office space, secretarial and administrative support. Upon completion of the Business
Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the three and nine months ended
September 30, 2021, the Company incurred $30,000 and $90,000, respectively, in fees for these services. At September 30, 2021, $5,000
is reflected in accrued expenses related to this agreement.
Advances
from Related Party
As
of December 2, 2020, the Sponsor advanced the Company $to fund certain offering costs in connection with the Initial Public Offering.
The outstanding balance under these advances was repaid upon the closing of the Initial Public Offering on December 15, 2020.
Related
Party Loans
In
order to finance transaction costs in connection with a Business Combination, the Sponsors or an affiliate of the Sponsors, or the Company’s
officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital
Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business
Combination, without interest, or, at the lender’s discretion.
On
January 11, 2021, the Company issued the Note to the Lender, which provides for borrowings from time to time of up to an aggregate of
$1,000,000. The Note bears no interest and is due and payable upon the date on which the Company consummates its initial Business Combination.
On various dates during the nine months ended September 30, 2021, the Company drew a total of $700,000 under the Note in accordance with
the Working Capital Loans.
On
April 28, 2021, the Note was amended to terminate the option for the Lender to convert the amount outstanding under the Note into Private
Warrants.
On
July 19, 2021, the Note was amended to increase the principal amount of the Note to $2,000,000.
On
October 13, 2021, the Note was amended to increase the principal amount of the Note to $3,000,000.
NOTE
7. COMMITMENTS
Registration
Rights
Pursuant
to a registration rights agreement entered into on December 10, 2020, the holders of the Founder Shares, Private Securities, equity participation
shares and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon
the exercise of the Private Securities or warrants issued upon conversion of Working Capital Loans) will be entitled to registration
rights. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities.
The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months
prior to the date on which these shares of common stock are to be released from escrow. In addition, the holders have certain “piggy-back”
registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company
will bear the expenses incurred in connection with the filing of any such registration statements.
GLOBIS
ACQUISITION CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER
30, 2021
(UNAUDITED)
Underwriting
Agreement
The
underwriters are entitled to receive the 402,500 equity participation shares upon the consummation of a Business Combination. The equity
participation shares have been placed in escrow until the consummation of a Business Combination. If a Business Combination is not consummated,
the equity participation shares will be forfeited by the underwriters. The Company accounted for the equity participation shares as an
expense of the Initial Public Offering, resulting in a charge directly to stockholder’s equity. The fair value of the equity participation
shares is estimated to be $4,025,000, based upon the offering price of the Units of $10.00 per Unit.
NOTE
8. STOCKHOLDER’S EQUITY
Preferred
Stock — On December 10, 2020, the Company amended its Certificate of Incorporation such that it is now authorized to issue
up to 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences
as may be determined from time to time by the Company’s board of directors. At September 30, 2021 and December 31, 2020, there
were no shares of preferred stock issued or outstanding.
Common
Stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. At
September 30, 2021 and December 31, 2020, there were 3,550,833 shares of common stock issued and outstanding, excluding 11,500,000 shares
of common stock subject to possible redemption which are presented as temporary equity.
Warrants
— The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination or (b) 12 months
from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination
or earlier upon redemption or liquidation.
Notwithstanding
the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective
within 90 days from the consummation of the Company’s initial business combination, warrant holders may, until such time as there
is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration
statement, exercise warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities
Act provided that such exemption is available.
Once
the warrants become exercisable, the Company may redeem the Public Warrants:
|
●
|
in
whole and not in part;
|
|
●
|
at
a price of $0.01 per warrant;
|
|
●
|
at
any time while the warrants are exercisable;
|
|
●
|
upon
not less than 30 days’ prior written notice of redemption to each warrant holder;
|
|
●
|
if,
and only if, the reported last sale price of the shares of common stock equals or exceeds $16.50 per share (as adjusted for stock
splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30-day trading period ending on
the third business day prior to the notice of redemption to warrant holders; and
|
|
●
|
if,
and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants
at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the
date of redemption.
|
If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for
redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless
basis,” as described in the warrant agreement.
The
exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the
warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company
be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period
and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to
their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect
to such warrants. Accordingly, the warrants may expire worthless.
In
addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with
the closing of a Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such
issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any
such issuance to the Sponsors or their affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates,
as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent
more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of
the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock
during the 10 trading day period starting on the trading day prior the day on which the Company consummates a Business Combination (such
price, the “Market Value”) is below $9.50 per share, then the exercise price of the warrants will be adjusted (to the nearest
cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $16.50 per share redemption trigger price
will be adjusted (to the nearest cent) to be equal to 165% of the higher of the Market Value and the Newly Issued Price.
The
Private Warrants and Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering,
except that the Private Warrants and the Placement Warrants are exercisable on a cashless basis, non-redeemable and holders of the Private
Warrants and the Placement Warrants have the option to calculate the fair market value based upon the last reported sale price of the
shares of common stock for the trading day prior to the date of exercise in lieu of the average reported last sale price of the shares
of common stock for the 10 trading days ending on the third trading day prior to the date of exercise.
GLOBIS
ACQUISITION CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER
30, 2021
(UNAUDITED)
NOTE
9. FAIR VALUE MEASUREMENTS
The
Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each
reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.
The
fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:
|
Level
1:
|
Quoted
prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
|
|
|
|
|
Level
2:
|
Observable
inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
and quoted prices for identical assets or liabilities in markets that are not active.
|
|
|
|
|
Level
3:
|
Unobservable
inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
|
The
following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September
30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such
fair value:
SCHEDULE OF FAIR VALUE ASSETS MEASURED ON RECURRING BASIS
Description
|
|
Level
|
|
|
September
30,
2021
|
|
|
December
31,
2020
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketable
securities held in Trust Account
|
|
|
1
|
|
|
$
|
116,155,627
|
|
|
$
|
116,150,000
|
|
NOTE
10. SUBSEQUENT EVENTS
The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, other than described below and the restatement discussed in Note 2, the Company did not identify
any subsequent events that would have required adjustment or disclosure in the condensed financial statements.
In
October 2021, the Company increased the principal amount available under the Note (as defined in Note 1 under Liquidity) to $3,000,000.